171 related articles for article (PubMed ID: 2526190)
1. Studies of human leprosy lesions in situ using suction-induced blisters. 1. Cellular components of new, uncomplicated lesions.
Rangdaeng S; Scollard DM; Suriyanon V; Smith T; Thamprasert K; Theetranont C
Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):492-8. PubMed ID: 2526190
[TBL] [Abstract][Full Text] [Related]
2. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
[TBL] [Abstract][Full Text] [Related]
3. Cell changes and soluble interleukin-2 receptors (Tac peptide) in leprosy reversal reactions using suction-induced blisters.
Theetranont C; Bhoopat L; Scollard DM
J Med Assoc Thai; 1990 Apr; 73(4):181-90. PubMed ID: 2394954
[TBL] [Abstract][Full Text] [Related]
4. Studies of human leprosy lesions in situ using suction-induced blisters. 2. Cell changes and soluble interleukin 2 receptor (Tac peptide) in reversal reactions.
Scollard DM; Suriyanon V; Bhoopat L; Wagner DK; Smith TC; Thamprasert K; Nelson DL; Theetranont C
Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):469-79. PubMed ID: 1976132
[TBL] [Abstract][Full Text] [Related]
5. Differences in predominant T cell phenotypes and distribution pattern in reactional lesions of tuberculoid and lepromatous leprosy.
Narayanan RB; Laal S; Sharma AK; Bhutani LK; Nath I
Clin Exp Immunol; 1984 Mar; 55(3):623-8. PubMed ID: 6423326
[TBL] [Abstract][Full Text] [Related]
6. Hepatic morphology in reactional states of leprosy.
Patnaik JK; Saha PK; Satpathy SK; Das BS; Bose TK
Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):499-505. PubMed ID: 2746077
[TBL] [Abstract][Full Text] [Related]
7. Inside the skin: the local immune and inflammatory milieu in leprosy.
Scollard DM
Am J Trop Med Hyg; 1991 Apr; 44(4 Pt 2):17-23. PubMed ID: 2042708
[TBL] [Abstract][Full Text] [Related]
8. Phenotype and cytokine expression of intralesional cells in borderline leprosy.
McClean K; G/Yesus E; Cenini P; Demissie A; Amare G
Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):380-8. PubMed ID: 7963910
[TBL] [Abstract][Full Text] [Related]
9. Type 1 reactions in leprosy--heterogeneity in T-cell functions related to the background leprosy type.
Laal S; Mishra RS; Nath I
Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):481-93. PubMed ID: 2958570
[TBL] [Abstract][Full Text] [Related]
10. Immunologic defects in leprosy patients. I. Evidence of immune aberration of suppressor-T lymphocytes in lepromatous leprosy.
Makonkawkeyoon S; Kasinrerk W; Dettrairat S; Vithayasai V
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):302-10. PubMed ID: 2142947
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte superoxide dismutase, catalase activities and hydrogen peroxide induced lipid peroxidation in leprosy.
Prasad CV; Kodliwadmath MV; Kodliwadmath GB
Lepr Rev; 2007 Dec; 78(4):391-7. PubMed ID: 18309714
[TBL] [Abstract][Full Text] [Related]
12. Renal involvement in leprosy.
Chopra NK; Lakhani JD; Pande RS; Modi KB; Pasle RK
J Assoc Physicians India; 1991 Feb; 39(2):165-7. PubMed ID: 1885476
[TBL] [Abstract][Full Text] [Related]
13. Tissue and blood T-lymphocyte subpopulations in erythema nodosum leprosum.
Modlin RL; Bakke AC; Vaccaro SA; Horwitz DA; Taylor CR; Rea TH
Arch Dermatol; 1985 Feb; 121(2):216-9. PubMed ID: 3156560
[TBL] [Abstract][Full Text] [Related]
14. Reactions in borderline leprosy.
Ramu G; Desikan KV
Indian J Lepr; 2002; 74(2):115-28. PubMed ID: 12708730
[TBL] [Abstract][Full Text] [Related]
15. Detection of transforming growth factor-beta 1 in dermal lesions of different clinical forms of leprosy.
Goulart IM; Figueiredo F; Coimbra T; Foss NT
Am J Pathol; 1996 Mar; 148(3):911-7. PubMed ID: 8774145
[TBL] [Abstract][Full Text] [Related]
16. Dermal extracellular matrix in cutaneous leprosy lesions.
Antunes SL; Gallo ME; de Almeida SM; Mota E; Pelajo M; Lenzl HL
Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):24-35. PubMed ID: 10407626
[TBL] [Abstract][Full Text] [Related]
17. Histopathology of skin and nerve and clinical classification in leprosy patients.
Lakshmi TS; Rao PN; Krishna AV; Kumar EC
Indian J Lepr; 1996; 68(3):258-60. PubMed ID: 8889614
[No Abstract] [Full Text] [Related]
18. Reduction of epidermal cell proliferation in skin lesions in lepromatous leprosy is greater than in indeterminate and tuberculoid leprosy lesions.
Palermo MH; Vugman I; Fleury RN; Zucoloto S
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):37-43. PubMed ID: 8627111
[TBL] [Abstract][Full Text] [Related]
19. In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosis.
Modlin RL; Hofman FM; Meyer PR; Sharma OP; Taylor CR; Rea TH
Clin Exp Immunol; 1983 Mar; 51(3):430-8. PubMed ID: 6221839
[TBL] [Abstract][Full Text] [Related]
20. The involvement of dendritic cells in the cutaneous lesions associated with tuberculoid and lepromatous leprosy.
Collings LA; Waters MF; Poulter LW
Clin Exp Immunol; 1985 Dec; 62(3):458-67. PubMed ID: 3910315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
